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ABSTRACT  
Background 
 
Prostate cancer is the most common form of cancer occurring in males in Australia after skin cancer. 
External beam radiation therapy (EBRT) is one of the main treatment modalities for prostate cancer. 
It is a procedure where beams of high-energy radiation are focused from outside the body onto the 
targeted area (tumor). The goal is to apply maximum damage to the tumor while subjecting minimal 
damage to the adjacent normal tissues. It is very important that the dose distribution from EBRT 
can be delivered as accurate as possible. Gel dosimeter is a three-dimensional method used to get 
the dose distribution, and is considered as a highly promising tool of radiotherapy dosimetry. The 
gels can be produced in similar modalities within the human being prostate by using special 
containers the size alike the prostate. There should be only monomers when the gels are prepared. 
Radiation-induced polymerization of monomers generates a polymer producing dose-dependent 
changes where the configurations and some properties of the system are different with monomers. 
In this work gel dosimeters will be used to determine the dose distribution, which in this case 
represented by the gel that is immersed in a water phantom. 
 
Purpose 
 
Is to evaluate and compare the dose distribution with conventional Four-Field and Intensity 
Modulated Radiotherapy (IMRT) plans by different beam energy and different commercial 
treatment planning systems. The aims of this work is to verify and compare the dose distributions 
by IMRT and Four-Field techniques, verify the beam energy effects in prostate cancer radiotherapy 
treatment, and compare Cadplan and Pinnacle 3 treatment planning systems (TPS) by the 
experimental results.  
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Method  
 
The PAG gels were prepared at the research laboratory of Professor D. Solomon at the Chemical 
Engineering Department of Melbourne University by following the procedures according to the 
literatures. The treatment planning of the gel phantom was planned by both Cadplan and Pinnacle 3 
treatment planning systems. Then, the gel dosimeters were irradiated by 6MV and 18MV photon 
beams using Varian Clinac 2100c linear accelerator. The collected data of the gel dosimeter was 
performed by a 1.5T magnetic resonance imaging (MRI) scanner. The data analysis was applied 
with a custom program written by the scientific computational program, Matlab 7.0.  
 
Results 
 
The dose distribution differences between IMRT and Four-Field were observed from 4.7% to 7.6% 
by average, depending on the beam energy, planning dose to planning target volume (PTV) and 
treatment planning systems upon irradiation. The dose distribution differences from different beam 
energy were found within 1%, without any significant changes. DVHs (Dose Volume Histogram) 
calculated by experimental data were used to analyze the TPS differences. It was verified there were 
no significant differences between both TPSs. 
 
Conclusions 
 
IMRT technique is more practical for prostate cancer radiotherapy with higher doses to planning 
target volume (PTV), while sparing more doses to the surrounding normal tissues.  There is no 
substantial significant evidence that can show any better effects from selecting irradiation beam 
energy. The effectiveness of the planning systems was evaluated and compared by the experimental 
data, which shows that both of the planning systems are effective to deliver dose with insignificant 
differences. 
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1. Introduction 
The first discovery of X-ray and radioactivity was by the German physicist Roentgen in 1895 and 
French physicist Becquerel in 1896 [1-7]. Since that time physics was utilized and incorporated into 
medical radiation. Medical physics is involved in applying physics into medicine, and consequently 
developed furthermore for diagnosing and treating of many diseases. X-rays has the ability to 
penetrate through several forms of objects, forming images that are projected over other objects. 
After few years, it was detected that x-rays could be used to kill cancer cells or reduce the sizes of 
tumors as a result of the release of high energy. This medical treatment approach is referred to as 
‘radiation therapy’. At the present, the main applicable methods for treating cancer diseases are 
achieved through: using concentrated ionizing radiation; utilizing chemotherapy, surgery and some 
others.  
 
Among the important techniques utilized for treating cancer diseases is by applying radiotherapy, 
which is a mean of directing ionizing radiation to kill tumor cells. When radiation is used to treat 
tumors they are directed towards a specific tumor to obtain the maximum possible dose, with a 
minimal dose of irradiation is applied to the surrounded healthy tissue around the tumor. The 
dose(8)- ICRU, “Radiation quantities and units,” ICRU Report 33, International Commission on 
Radiation Units and Measurements, Washington, D.C. 1980-where one can calculate: Energy 
Absorbed Per Mass of Irradiated Medium in units of Gray (Gy), where 1 Gy = 1 J/kg. 
 
To deliver a radiotherapy treatment by ionizing radiation; hence, an appropriate and efficient 
evaluation of quantitative and dose calculations should be taken into account while being deposited 
into a patient’s body. Here, radiation dosimeter is considered an important part of medical physics 
that handle such dose calculations depending on the quality of ionizing radiation utilized in 
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radiotherapy [8]. 
  
1.1  Evolution of linear accelerators 
 
1.1.1 Historical background of accelerators 
 
Since our study concentrates on using irradiation to treat cancers, we have chosen prostate cancer 
where its major treatment is via radiation therapy. Radiotherapy is mainly delivered by X-rays 
emitted by linear accelerators where radiation therapy uses high energy photon and electron beams 
with a mean energy of 2–10 MeV. The production of radiation falls into two divisions: the 
production of low and high energy x-rays. Despite the fact the two divisions varies tremendously in 
the practical implementation; however, both they take up the same physical mechanism of radiation 
production—the bremsstrahlung interaction [9]. So, it is necessary to provide a brief background on 
linear accelerators. Linear accelerators emerged by the 1940’s of the last century based on three 
evolutionary origins, and each model is constructed based on a specific design emerging from a 
unique acceleration type.  
 
1.1.2 X-ray tubes 
 
In 1913, William Coolidge invented and revolutionized the method in which x-rays were produced. 
His invention constituted of a vacuum tube that later became to be known as the Coolidge x-ray 
tube. Before x-rays were produced, people were utilizing the Crooke’s tube updated forms which 
was invented by Wilhelm Roentgen, but these tubes were not efficient due to their energy limitation 
[10], and there was a demand and need to make tubes that can be capable to deliver higher energies 
more efficiently, which led to the emergence of hot-cathode tube. The function of the hot-cathode 
tube is when high-energy radiation is directed through what is known as linear accelerator. The 
beam of electrons is produced and speeded up through a waveguide increasing their energy from 
keV to MeV range. These electrons will hit a tungsten object and generate x-rays. The X-rays 
produced in the 10–30-keV range are identified as grenz rays, whereby the energy range for 
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diagnostics units is about 30–125 keV; the ortho-voltage units produce x-rays from 125–500 keV 
[11] 
 
1.1.3 Cobalt 60 teletherapy 
 
Since the x-ray tubes were limited in their penetration when delivering radiation;thus,  that period a 
search began for a better penetrating beams. In 1951, the first cobalt 60 (60Co) teletherapy unit was 
built in Canada. The spectrum for 60Co has two photo-peaks, one at 1.17MeV and the other at 
1.33MeV giving a mean photon energy of around 1.25MeV. This machine was had a much more 
penetrating radiation in comparison to the x-ray tubes discussed in section 1.2.1. Although their 
photon energy is quite low compared to today’s linear accelerators, the cobalt 60 teletherapy unit 
still provides reasonable skin sparing properties when a maximum dose is achieved at 0.5cm [12]. 
 
1.1.4 The modern linear accelerator 
 
Linear accelerators or linacs were first produced for physics research, and later scientists discovered 
the advantages and the benefits of accelerators when are used in the clinical setting [13]. The first 
clinical linear accelerator was introduced in 1953 at the Hammersmith Hospital in London [14], and 
the first clinical treatment for a patient occurred in 1956 [15]. Since then, clinical linacs have 
progressed a long way. The first linac at the Hammersmith Hospital produced an 8MV x-ray beam. 
These days’ linacs can produce photon beams from 4MV to 25MV, as well as electrons with 
energies ranging from 4MeV to 25MeV. 
 
1.2   Prostate Cancer Treatment 
 
1.2.1   Anatomy of Prostate 
 
The prostate is a gland with the size of a walnut located in the male pelvis lying behind the pubic 
bone, in front of the rectum, and immediately below the bladder. Its size is usually 3-4 centimeters 
in length and 3-5 centimeters in width (Figure-1). The prostate surround the urethra from different 
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directions. The urethra moves through the center of the gland by transporting urine from the bladder 
to the external urethra. The seminal vesicles are attached to the prostate on both sides of the gland, 
and excrete substance that blends with the prostatic fluid to form the semen. The prostate gland is 
an important organ, which is involved in the human reproduction process composed of several types 
of complex cells and their interaction with each other are poorly understood till nowadays [16]. The 
male hormone testosterone and its derivative hormones have an essential role in the growth and 
function of the prostate. The anatomical division of the prostate allows amalgamation of the cellular 
parts to form an efficient mixture of fluids in order to allow human reproduction. Hence, after men 
reach old age this same composition is involved in adding to several of man’s health problems, 
which due to the rapid cellular growth that can lead to damage of important body functions. 
 
 
 
 
 
 
 
Figure-1. The location of the prostate. 
http://www.prostatehealth.com/anatomy.htm 
 
1.2.2   Prostate Cancer 
 
Cancer of the prostate is a disease where prostate cells multiply in an uncontrolled fashion. Tumors 
become cancerous when cells divide in unorganized and unpredictable form. When tumors start 
growing they commence pressing on the nearby healthy tissues utilizing oxygen, which is usually 
developed by healthy cells. Also, prostate cancer produces protein signals allowing the start and 
development of new blood vessels for the tumor. With the prostate tumor’s growth, cancer cells 
might spread to the whole gland, lymph nodes, bones and other organs. 
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In males, prostate cancer (in 1998, around 9,869 new cases were diagnosed), is the most common 
recorded cancer, while in females it is breast cancer, and is considered as the second common 
cancer causing death-taken from “Incidence and Mortality Data for 1998,” Cancer Australia 1998; 
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Canberra 
October 2001). In the past decade and till nowadays, prostate cancer is considered as one of the 
most frequent cancers among men in the western countries [17], and it is the most common non-
skin cancer in men in the United States, and second after lung cancer causing death in men as a 
result of cancer. In 2000, it was estimated that there will be 170,000 new cases of prostate cancer 
and 31,000 deaths in the United States. As for 2004, it was estimated that around 230,000 men will 
be diagnosed with prostate cancer, and nearly 30,000 will die of the disease [18] 
 
1.2.3   Treatment options for prostate cancer 
 
There are different treatment alternatives: radiation therapy, surgery-Radical prostatectomy-
removing parts of the prostate gland along with the neighboring tissues and structures), 
chemotherapy (utilizing different chemotherapeutic regimes to destroy tumor cells or weakens their 
capability to divide and multiply), hormone therapy (utilized especially in metastasis cancers, and 
functions by reducing androgen production and excretion), and the observational period (by 
observation and screen PSA levels with necessary instant and essential treatment). Treating prostate 
cancer by radiation therapy is considered one of the main treatment ways [19, 20, 21]. For localized 
treatment method is done by introducing high-energy particle rays by directing a high radiation dose 
to the original volume, and accompanied with a minimal dose to all other neighboring normal 
tissues and organs [21]. Hence, the intended dose dispersal will witness powerful dose gradients 
from all sides and far from the original target. It is the function of radiotherapy dosimetry to supply 
the necessary reliable and accurate information for the required dose distributions where a clinical 
decision could be built upon [22]. There are generally two radiation treatment approaches for 
prostate cancer: internal radiation therapy (Brachytherapy) and external beam radiation therapy. 
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1.3   Types of Irradiation 
 
1.3.1   Brachytherapy 
 
Brachytherapy is known as the process of distributing radiation from a near distance, i.e., 
immediately nearby to or within the patient range. It uses fastened radioactive resources to convey 
radiation by interstitial, intra-cavitary, or surface application. By using brachytherapy, a high dose 
is applied near the cancerous tumor with a fast dose fall-off around normal tissue. After-loading-
devices they are used to enable positioning of the sealed radioactive sources with remote control. In 
1906, the United Kingdom’s Saint Bartholomew’s Hospital was the first to use radium 
brachytherapy; however, in 1913 brachytherapy was utilized for the first time by doctors to treat 
prostate tumors [23]. Brachytherapy is a treatment method that utilizes very small radioactive 
pellets (where each is nearly the size of a piece of rice) which are deep-rooted into the prostate 
tumor under the accurate ultrasound supervision [24]. These pellets could be left in for a temporary 
period or permanently. The pellets will maintain discharging very small amounts of radiation for 
several weeks or months duration. Brachytherapy treatment is divided into two main types: 1) Intra-
cavitary, where the emitting sources is positioned within the body cavities near to the tumour 
volume; 2) Interstitial, where the sources are situated within the tumor volume. So, the two main 
methods of prostate brachytherapy are: permanent seed implantation, and high dose rate (HDR) 
temporary brachytherapy. The permanent seed implants necessitates infusion of nearly 100 
radioactive seeds into the prostate gland where they release their radiation at a minimum dose rate 
for several weeks or months duration, and after that the seeds stays in the prostate gland 
everlastingly. High-dose, or high-energy, seeds are fixed for less than 24 hours and distribute a 
condensed dose of radiation directed towards the tumor [25].  
 
1.3.2   External Beam Radiation Therapy 
 
External beam radiation therapy (EBRT) is one of the earliest techniques used to treat prostate 
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cancer. With external radiation, electrons are accelerated so that they hit a metallic target and yield 
photons.  
 
External beam radiation treatment is when the radiation beams are directed from the outer surface 
of a patient’s body and focused on to the tissues that contain cancer cells. The applied radiation 
beams are alike to those of the normal chest x-rays or the rays rising from the sun but with greater 
energy. The high energy radiation inflicts grave impairment to the cancer cells leading to their death. 
However, the normal cells have a superior capability than cancer cells in order to repair this type of 
damage, and can have the ability to survive.  
 
1.3.3   Conventional radiotherapy  
 
Conventional radiotherapy is considered as the classical EBRT using 60Co or linacs to treat patients 
through modulating field by adding compensators or wedges applied, which is effective for 
clinically organ-confined prostate cancer with a low incidence of severe complications [26]. The 
number of irradiation fields is adjusted with various cases. The most common treatment option is by 
utilizing four-field or box field planning. In some cases, compensators and wedges are utilized to 
modulate the target shapes. For prostate cancer, a four-field planning is the conventional option; 
nevertheless, there are some new treatment techniques that were invented, such as Three 
Dimensional Conformal Radiation Therapy (3D-CRT) [27], and Intensity Modulated Radiotherapy 
(IMRT) and proved to be effective in treating prostate cancer. 
 
The 2D method has a beam display consisting of 4 beams, with a parallel contrasting anterior 
posterior coupling and a parallel-divergent right and left lateral coupling. This field organization is 
known as a “box” method due to the box similar-form of high-dose irradiation area. Treatment 
access is usually planned by a simulator films, and the dose dispersal is normally measured on a 2D 
treatment planning system. [28]. However, the Four Field Box it is a method of four beams (two 
opposing pairs at right angles) generating a comparatively high dose box form zone. The presented 
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area with highest dose appears in the volume segment that is radiated by the four fields. This 
displaying is generally applied for treatments in the pelvis, where major lesions are central (e.g. 
prostate, bladder and uterus) [25]. 
 
1.3.4   Intensity Modulated Radiotherapy-IMRT (MLC)  
 
Intensity-modulated radiation therapy (IMRT) is a sophisticated method applying high-specific 
radiotherapy by utilizing computer-controlled x-ray accelerators to deliver specific radiation doses 
to a malignant tumor or specific areas within the tumor. IMRT is a new technology that is being 
adopted in a quite few facilities as a standard treatment protocol for cancers [29].The radiation dose 
is built to suit the three-dimensional (3-D) shape of the tumor by adjusting or controlling the 
intensity of radiation beam in order to deliver a higher radiation dose to the tumor, and at the same 
time reducing as much as possible radiation exposure to the neighboring normal tissues by applying 
Multi-leaf Collimators (MLC) (Fig-2). Treatment is applied cautiously to patients by utilizing 3-D 
computed tomography (CT) images in combination with computerized dose calculations to 
establish the dose intensity guidance, which will fit best the tumor shape [30]. 
 
Hence, the mixture of several intensity-adapted fields coming from various beam directions will 
produce a traditional adaptable radiation dose that amplifies tumor dose, and at the same time 
protect adjacent normal tissues. When applying IMRT compared with conventional radiotherapy 
techniques, higher and more effective radiation doses could be safely delivered to tumors, and with 
lesser side effects due to the ratio of normal tissue dose to tumor dose which is reduced to a lowest 
point. Also, IMRT has the capacity to minimize treatment toxicity [29], such clinical benefits have 
been detected in patients treated for prostate cancer.  
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Figure-2 The Varian 120 leaf Multileaf Collimator 
 
Intensity modulated radiation therapy (IMRT) is the newest and extensively developed method of 
external beam radiation that is present nowadays [31], which is considered as the third generation, a 
result of peak evolution in this field commencing with the 4D beam radiation, and then evolving to 
second generation with 3D conformal radiation. What characterizes IMRT from the other previous 
techniques is the capability of providing a high uniformly doses of irradiation to the prostate and at 
the same time not affecting the rectum and the bladder. The ability of IMRT to achieve this, is by 
adjusting the strength of radiation beam over the width of the beam see (Fig-3) 
 
 
 
 
 
 
 
          
 
 
Figure-3. Intensity Modulated Radiation Treatment (IMRT). Thousands of tiny “beamlets” from 
numerous route; largest doses targeting with maximum saving of normal tissue [21]. 
 
 
This adjustment is important because of the spherical target form of the prostate. 
When a beam of radiation is used, the thicker and middle portion of the prostate needs 
comparatively higher doses of irradiation to be able to go through the entire gland while the thinner 
part of the prostate gland i.e., the marginal part of the gland is targeted with a minor amounts of 
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irradiation. Thus, only IMRT has these characteristics of adjusting the beams’ strength by allowing 
for these anatomical realities to be achieved.  
Linear Accelerator Model Used in Our Experiment 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-3a Varian 2100 C/D linear accelerator 
 
The linear accelerator used in our experiment (Fig 3a & 3b) is organized for multiple energies 
utilizing 6, 9, 12, 15 and 18MeV (mega electron volts) for electrons and for photons; we employed 
6MV and 18MV (megavolts).  
 
 
Major Components of the Linear Accelerator 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-3b Cross section of a Varian 2100 C/D linear accelerator 
         (Clinic Accelerators, Varian Medical Systems, Palo Alto, 2000) 
1. Collimators 
2. Ion chambers  
3 Carousel 
4. Bending magnet 
5. Steering coils 
6. Focal spots 
7. Energy switch 
8. Electron gun 
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1.3.5   Varian 120 leaf Multileaf Collimator (MLC) 
 
The key objective of utilizing radiation therapy is to transmit the dose to a target and without 
destroying the surrounding healthy tissues. The application of IMRT enhances the increase of the 
dose transmitted to the target, and at the same time able to save the nearby healthy tissues from 
getting affected. Since the emitted beam from irradiation can be adjusted in several numbers of 
ways e.g. blocks and wedges; hence, this performance is solely applicable when dynamic IMRT is 
being adopted [32]. 
 
In conformal radiation therapy, the MLC substitutes the field shaping blocks [33]. Utilizing MLC 
for static treatments is considered resourceful, precise, and cost-effective. Prior to the initiation of 
MLCs, weighty bulky blocks were employed to form the field, which was needed to be 
implemented below the head of the linear accelerator; these procedures needed time to produce and 
setting them up [34]. Now, more patients could be treated by a linear accelerator with an MLC 
imbedded within. Therefore, IMRT is an expansion of CRT with additional important equipments, 
which is associated of utilizing a multi-leaf collimator (MLC) see (Fig-2) in a dynamic or 
segmented mode [32, 35]. The MLC employed in this project is a Varian Millennium 120 leaf 
multi-leaf collimator. 
 
1.4   Latest Irradiation Technologies  
 
1.4.1   IMRT Methods  
 
Most of the IMRT general methods need to utilize the opposite or what is known as the “inverse” 
treatment planning programs. As a start we should initially start with the physician’s instructions 
and directions that are provided to us associated with the dose aiming to hit the required target and 
avoid affecting the normal tissues. The organizer will establish the framework for delivering the 
total number of beams, beam routes, provision method and utmost suitable convolution of strength 
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configuration. The program enhances the effectiveness of the plan and restores the strength mode of 
each beam required to estimate the intended dose dissemination. As for IMRT approaches utilizing 
the traditional MLC’s include:  “Stop-and-shoot” static IMRT where there is application of several 
MLC figures per area (SMLC-IMRT), which consists of both forward and inverse planning 
examples; Dynamic IMRT with stable gantry and moving MLC result in (DMLC-IMRT) – 
comprises of both complete dynamic and pseudo-dynamic; Intensity-modulated arc treatment 
utilizing a complete area of MLC (IMAT). 
 
The “Stop and Shoot” SMLC-IMRT holds great benefits for applying this method as the following: 
1) It is feasible during accessing the confirmation of strength approaches, 2) it is quite simple to be 
understood in the clinical setting, 3) simple to continue the suspended treatment, 4) comparatively 
an unsophisticated accelerator control system is required, and 5) both the forward and inverse 
approaches of organization are feasible. However, the weaknesses of this method: sophisticated 
problems demands numerous segments and the time period needed for therapy can be substantial.  
 
1.4.2   Dynamic IMRT Methods with Conventional MLC’s 
 
The truly dynamic IMRT adjusted leaf speed with stable beam strength (MSKCC-Memorial Sloan 
Kettering Cancer Center) is like the sliding window approach seen below (Fig-4). The dynamic 
“step-and-shoot” (Stanford Medical Centre and others - including UCSF- University of California, 
San Francisco) used large numbers of tactical MLC shapes per area, where the beam moved to face 
a different direction between segments [36]. However, the Intensity Modulated Arc Therapy (IMAT) 
utilizes several arcs by transporting single strength level. Hence, each arc is composed of various 
MLC sub-areas-persistently altered while gantry revolve. 
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Figure-4 Sliding window 
Lynn J. Verhey, Ph .D. Dept. of Radiation Oncology 
University of California, San Francisco 
<http://www.aapm.org/meetings/99AM/pdf/2780-22797.pdf> 
 
1.4.3   Dynamic DMLC-IMRT 
 
The benefits of this design IMRT has a quicker beam distribution than the static methods, which 
can produce more sophisticated dose delivery, and can generate various strengths. However, the 
shortcoming of this method is where the leaf edge effects can produce dosimetric errors when the 
areas’ dimensions are minute. Also, in this model it is hard to confirm leaf modes, and also possibly 
it is harder to recuperate after disruption of therapy [36]. Another studied rotating leaf motion is the 
calculation algorithms with concentration on radiation effectiveness, and the dimension of 
collimator rotation and the number of section. Furthermore, they assessed the method by 
exemplifying the tendency of the algorithms to produce revolving leaf sequences for the required 
fluence maps. Comparative analysis also was performed between this technique and the traditional 
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sliding window and step-and-shoot techniques. Results revealed enhancement in spatial resolution, 
decrease in the interleaf outcomes and outmost producible area dimension better than the traditional 
methods. Clinical application of these improvements could be seen instantly with static rotational 
distribution, even though enhanced dosimetric form of the MLC will be needed for the dynamic 
distribution [37]. 
 
The reason for choosing and applying dynamic ‘MLC’ Methods is because IMRT delivers more 
accurate descriptions of the distributed radiation treatment volume with changeable beam strength 
across every treatment field. The mixture of beam concentration, which is regulated by mobilizing 
the MLC leaves, when the form beam positioned by the MLC and the beam angle situated by the 
gantry angle of the linear accelerator, this permits a treatment plan to increase in its accurate volume 
description by elevating the spatial decree and shortening the penumbra; benefits are much superior 
then those obtained with conformal irradiation therapy. Dose increase could be applied at a higher 
level while treating less normal tissue with maintaining a less complication percentage. IMRT 
necessitates the utilization of CT slices in order to reconstruct the target in 3D. The three-
dimensional imaging permits a superior observation of the target region and for the possibility of a 
much enhanced treatment plan. 
 
1.5   Gel Dosimetry  
      
1.5.1   History of Gel Dosimetry 
 
Day & Stein [38] and Andrews [39] were the first to work on Gel dosimetry for the clinical 
dosimeter, and in the last twenty years the number of researchers contributing to the growth of 
information in the field of gel dosimetry has grown widely [40, 41]. From 1950's, researchers found 
that radiation is able to form color alteration within dyes, and they started to experiment radiation 
doses within sensitive gels [38, 42]. Afterwards, nuclear magnetic resonance (NMR) relaxation 
properties were utilized to scan gels when injected with traditional Fricke ferrous sulphate solution 
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[43], followed by measuring dosimetry solutions [40]. The Fricke gels, containing Fe2+ ions in 
ferrous sulphate solutions are usually scattered all over a gel matrix. The Fe2+ ions are transformed 
to Fe3+ ions with an equivalent alteration in paramagnetic laws making possible to be measured 
through the use of NMR relaxation measurements [40] or by applying optical computed methods 
[44]. Because of the limitations in the diffusion properties [45], polymer gel dosimeters started to be 
used [46, 47], and now they are well known as BANG-type [47] or PAG-type monomers [48], 
which are normally scattered in an aqueous gel matrix. The monomers are subjected to 
polymerization reaction by radiation as a performance of the absorbed dose leading to a 3D polymer 
gel matrix. Polymer post-irradiation is manipulated by the NMR relaxation traits leading to 
alterations in various physical properties to measure the absorbed radiation dose with the possibility 
in forming real 3D dosimetry [49, 50]. However, when the polymerization is inhibited by oxygen 
[47, 48] in BANG-type or PAG-type polymer gel dosimeters, all free oxygen are needed to be 
extracted from the gels. Over many years this process had been reached by bubbling nitrogen 
process via gel solutions through loading the phantoms in a glove box that is supplied with nitrogen. 
In MAGIC gel [51] the oxygen is adjoined in a metallo-organic complex form, eliminating the 
setback of oxygen restrain and allowing polymer gels to be formed in the laboratory with true 3D 
dosimetry [52]. In addition to MRI [53], other quantitative methods are utilized to calculate for dose 
scanning, which includes optical [15] and x-ray computer tomography [54], vibrational 
spectroscopy [46] and ultrasound [49]. Several applicable forms that are radiologically tissue 
analogous in the clinical setting have been found [55], and gel dosimeters have been documented as 
well with the preceding DOSGEL conferences on radiotherapy gel dosimetry [56]. When Gore [40] 
invented gel dosimetry, he acknowledged that ferrous sulfate Fricke dosimeter [43, 57] could be 
tested with magnetic resonance rather than using spectrophotometry [40]. By stabilizing the Fricke 
solution with gelatin or agarose, this permitted the attainment of dose distribution in three 
dimensions space, and applied the MR imaging to capture the absorbed dose delivery. The T1 
relaxation parameter differed according to the dose’s percentage. Nevertheless, the ferric ions that 
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are formed by the absorption of radiation scattered through the gel or agarose matrix they driving to 
a decrease in the signal strength, and leading to a loss of spatial records [45]. To decrease the 
diffusion process, a gelatin matrix with a poly vinyl alcohol (PVA) matrix requires to be added, 
which is less absorbent to ferric ions [58]. Other researchers did create other ways to postpone the 
delay of dispersion; nevertheless, imaging needs to be done immediately after undergone the 
process [59]. In 1993, gels with acrylic monomers were substituted by Fricke solution, [46, 60]. The 
inverse of T2, or R2, the relaxation rate was detected to differ with dose ratio, and MR imaging of 
polymer gels showed that they are able to produce quantitative dose dispersions [46]. Different gel 
types have been manufactured by substituting Bis and acrylamide for acrylic acid or methacrylic 
acid; thus, increasing gels’ sensitivity, diminishing toxicity [48, 61] and creating a new generation 
of polymer gel dosimeters with oxygen detectors [51].   
 
1.5.2   Chemistry and Physics of Polyacrylamide Gel Dosimeters 
 
In the last decade, extensive research took place on the methods of utilizing polyacrylamide gel 
(PAG) dosimeters [39, 40, 57] to identify and calibrate 3-D radiation dose dispersion. A polymer 
gel which is composed of monomers was injected in a gel matrix and polymerizing as a reaction is 
subjected to ionizing radiation. The success of this method is due to large polymer molecules are 
unable to pass through the gel matrix, where spatial dose information is preserved and a 3D 
recording of the collected dose results. Multiple types of polymer gel, depending on different 
monomers, are being examined for radiation dosimetry. These different types are PAG (or BANG-
type), VIPAR and HEA gels [47, 62-65] as well as with the new normoxic systems such as MAGIC 
and MAGAS gels, [51, 62, 66]. The particular polymer gel system of interest in this work is 
polyacrylamide gel or PAG. 
 
Typical PAG dosimeters, are a mixture of acrylamide, N,N’-methylene bisacrylamide, gelatin and 
water that are irradiated using the preferred radiation dose distribution. Water radiolysis [67, 68] 
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drives configuration of free radicals, and initiate polymerization. Free radical copolymerization of 
acrylamide and bisacrylamide take place by the mechanism revealed in (Figure-5) [67; 69]. 
Polymer chains grow by disseminating reactions, which relates both to acrylamide (having one 
vinyl group) and bisacrylamide (having two vinyl groups). Comparatively, bisacrylamide are used 
up much rapidly [64, 67, 70] than acrylamide because of extra vinyl group. When bisacrylamide is 
taken up by dissemination, a pendant vinyl group (known as a suspended double bond) is produced 
along the polymer chain. This vinyl group can act in response with a developing polymer chain to 
shape a cross-link (reaction c in Fig 3), but most often utilized by primary cyclization (reaction b in 
Fig 5). The primary cyclization reaction is so positive because it ends in a convenient seven 
member ring [67; 72]. An alternative cross-linker molecule with a greater distance between its vinyl 
groups could end with more cross-links leading to utilization of a lesser concentration of cross 
linker, because the quantity of bisacrylamide incorporated in PAG guidelines is very close to water 
solubility in limiting of bisacrylamide. The quantity of polymer that accumulates and the cross-link 
density of the polymer chains affecting water molecules are dissipated within the accumulated 
polymer phase, which can be seen through NMR or magnetic resonance imaging [46, 47, 67]. The 
process of chain-transfer reaction could stop the growth of a polymer chain (reaction e), leading to 
a dead polymer molecule, and a new development of polymer chain, or by execution with another 
free radical (reaction f in Fig 5), pushing towards damaging of the free radicals. Jirasek and Duzenli 
[70] demonstrated that elevation in the concentration of gelatin in the PAG guidelines diminishes 
the rate of monomer use up leading to development of polymer chains and responding with gelatin 
to generate gelatin radicals that are decelerated to recommence polymerization [67, 73]. Several 
obstacles prevent the utilization of PAG dosimetry in extensive clinical setting: (i) the existence of 
long life span radicals leading to a persistent polymerization despite the cessation of irradiation [67, 
74], (ii) difficult to improve the edge zones, especially when a new polymer forms near these zones 
while the radiation dose is elevated to high level, and (iii) monomer toxicity. Problems (i) and (ii) 
are connected to the physical and chemical properties that might lead to an un-precision dose 
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calibration, whereby the problem (iii) is considered more as a serious biological and human 
problem. It is a major concern of handling polymer gel dosimeters and how to get rid of them. 
Because the technological aspect of this technique is still considered in its premature form and 
haven’t reached to a better method—due to difficulty of reducing the long-lived radicals, need for further 
edge enhancement and decrease in monomer toxicity; however, the benefits that is being provided by 
utilizing this technique waves much more than the hazards and the problems that we might 
encounter, which could be maintained and contained under control.  
 
 
Figure-5. The free radical copolymerization method for acrylamide and bisacrylamide. [67] 
 
1.5.3   Polymer Chemistry and Hydrogel Systems  
 
Hydrogels are classified by researchers as a group of polymers that are capable to hold up large 
quantity of water and not being dissipated due to their physical or chemical cross-linkage of the 
hydrophilic polymer chains. Hydrogels could be constructed up first from what is known as 
monomers (A), then pre-polymers (B) or followed by accessible hydrophilic polymers (C). 
i. The construction of hydrogels from monomers (Fig-6A) 
The first stage begins with the co-polymerization of hydrophilic monomers and those poly-
functional co-monomers that act as cross-linkers, which guides the pathway to the production of 
hydrophilic system structures. From what is known as the most common used monomers are the 
hydrophilic (meth) acrylates and (meth) acrylamides [75, 76, 77]. Among the first instance had been 
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documented [75, 76] was a copolymer of (2-hydroxyethyl) methacrylate (HEMA) and 
ethyleneglycol bismethacrylate (EGDMA). Polymerization of vinyl monomers is most frequently 
initiated via radical initiators (peroxides, azo-compounds). Radicals are formed by heating, and by 
utilization of a redox initiator (e.g. ammonium persulfate + N,N’-tetramethyl ethylene diamine, 
TEMED) or a photo-initiator. Another way to commence the radical polymerization method is by 
high energy irradiation. 
 
ii. Synthesis of hydrogels from prepolymers (Figure-6B) 
Hydrogels have been made up by cross-linkage of low molecular weight hydrophilic polymers or 
oligomers. For example, the reactions α,ω-hydroxyl poly (ethylene glycol) with a diisocyanate 
during the existence of a triol as a crosslinker [76, 78, 79] drives the reaction for the development of 
cross-linked hydrophilic polyurethanes. An approach is the change of the hydroxyl end groups of 
poly (ethylene glycol) into (meth) acrylate which lead to be cross-linking through radical 
polymerization[75,80].                                     
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Figure-6. Preparation methods of hydrogels: starting from monomers (A), prepolymers (B) or existing 
hydrophilic polymers (C) [75].  
 
 
iii. Synthesis of hydrogels from polymers (Figure-6C) 
To form hydrogels, which being considered as an important step, chemical cross-linkage of 
hydrophilic polymers should take place? A well known example is the formation of stationary 
stages for gel filtration chromatography. As an example: Sephadex→ is a system of dextran 
interlinked with epichlorohydrin. Some other cases are the proteins cross-linked with formaldehyde, 
gluteraldehyde or a polyaldehyde [75, 81, 82]. Ionic polymers can be cross-linked through the 
addition of di- or trivalent counter-ions, such as the gelation of sodium alginate by adding of Ca+2-
ions (Figure-7). 
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Figure-7. Gelation of sodium alginate by addition of Ca2+-ions. [75] 
 
Polymers like gelatine and agarose could be prepared from hydrogels upon cooling an aqueous 
solution. The gel making is due to helix-made up by involving of the helices, and developing an 
interchange region (Figure-8). These physically cross-linked hydrogels have a sol-gel alteration 
temperature. Enduring cross-linkage could be reached by successive chemical cross-linkage.  
 
Figure-8. Gelformation [75] 
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1.5.4   Applications of Gel Dosimetry 
 
Gels dosimetry has beneficial and apparent characteristics enabling them to become the leading role 
in radiation therapeutic dosimetry, especially when traditional conventional dosimeters were un-
applicable in the clinical setting. These features have the tendency of calculating three dimensional 
dose distributions; incorporate dose precisely, and over a rather extended fields; there is tissue-
equivalence; a high spacial resolution; and absence of dependency on energy on top of most of the 
kilovoltage and megavoltage range. Gel dosimetry are considered comparatively safe to create and 
handle them, even though some materials are considered toxic such as acrylamide, where protection 
is needed until the material is being mixed. To date there are different types of gel dosimetry 
including basic dosimetry (depth dose, penumbra, wedge profiles) in photon, electron, neutron and 
proton beams; dose dispersing from imaging procedures; conformal therapy, stereotactic 
radiosurgery, and intensity-modulated radiation therapy (IMRT); dose distributions around 
brachytherapy sources (low- and high-dose rate, and intravascular sources); internal dosimetry 
(iodine-131 doses); and assessment heterogeneities of tissues. As for the basic dosimetry they have 
limitations; for example, the probability of depth dose in photon and electron beams [42, 83, 84]. 
According to Oldham [85] gel dosimetry has revealed its beneficial use by confirming with 
uncomplicated measures for the numerous-areas, and are more multifaceted anatomical conditions 
involving tangential breast therapy [86, 87] and scalp therapy using electron beams [88]. It is hard 
to calculate the lively performances like the programmable wedge filter, by using ionization 
chambers or diodes, and moreover the film is frequently utilized to supply data in a single plane. 
Gels proved to be beneficial in confining the dose dispersions from programmable wedge filters, 
and permit the disseminations in several planes in order to be determined in a single contact [89].  
 
When gels are utilized to show the dose dispersion from specific treatments, both come from 
reliable multi-source cobalt units and from linear accelerators [90- 97].  
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Due to the complexity nature of dose distributions around brachytherapy researchers have 
encouraged the use of gel dosimetry. This method in documenting and dose dispersion around a 
high dose rate was already demonstrated by Schreiner [98], Olsen [99], Maryanski [47] and was 
further confirmed by Heard [100]. However, there were some problems researchers had faced with 
while applying a high dose gradient around brachytherapy, where in some gel types the 
development of polymer particles resulted in gel’s contraction, which could lead to alteration in the 
dose dispersion towards high-dose areas [101]. 
 
Furthermore, it is been suggested by researchers that the presence of high dose rates especially near 
the brachytherapy sources, those related to HDR after loaders, could initiate temperature gradients 
and could affect the polymerization of acrylamide monomer gels [101]. Among the errors that could 
emerge when there is dispersion of monomers (or ferrous and ferric ions in Fricke gels) is through 
the vertical dose descents [101, 102]. Furthermore, utilization of gels to calculate dose dispersion 
from LDR sources needs longer displaying time, where the dispersion of monomers or ions could 
bring significant mistakes; thus, gels with high dispersal rates should be avoided in these 
calculations. Also, another problem faces the utilization of gel dosimetry for LDR brachytherapy 
where they show dependency with low energies. From the research, it shows that a polymer gel 
dosimeter reacts to radiation with a range of 20 keV – 60 keV [103, 104]. Some researchers claimed 
that the MAGAT gel is mostly water-equivalent over a wide scope of energies [103, 105]. 
Alteration in the mass shrinkage coefficient of polymer gels through the irradiation process could 
cause some errors in the dose dispersals that are calculated nearly at low-energy sources. 
 
1.5.5   PAG Gel Dosimetry 
 
X-ray computed tomography (CT) is becoming the future technique in obtaining three dimensional 
(3D) doses documentation from polymer gel dosimeters [108-110]. Among the benefits in using CT 
gel dosimetry lies in it’s easiness to be utilized at a lower cost than MRI and other hi-tech 
equipments, its convenience for specialized cancer hospitals, and proven to have clinical benefits 
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[54, 110]. However, the setbacks in using PAG gel dosimetry lies in their poor dose discrimination 
which could be attributed to the lower sensitivity of CT contrast to dose, and this is a consequence 
of a relaxation density alteration occurring upon polymerization [62, 86, 110].   
 
On the other hand, Baldock et al. [48] were able to illustrate an easy technique for a less expensive 
made on a large scale PAG, and utilizing it in MRI radiation dosimetry. However, researchers 
before they worked on MRI radiation dosimetry they utilized ferrous sulphate solutions, which were 
built-in into a gel matrix in order to control the space MRI signature. These types of gels showed 
certain restrictions upon utilizing them, and included dispersal of ions in the ferrous/ferric system 
[48].  However, due to the restrictions in Fricke gel dosimetry, this has led to the creation of a new 
dosimeter, which depended on creating polymerization based on radiation exposure and 
interconnecting of acrylic monomers injected in a gel matrix [48]. In order for Baldock et al. [48] to 
prepare and create PAG, they required a complex groundwork and construction facilities more than 
it is in Fricke-gels. This was related to the necessity to take out oxygen molecules from the aqueous 
gel system, which is because of the influence of oxygen inhibitory effects causing the formation of 
free-radical chemical processes through radiolysis. The manufactured PAG was composed of 5% 
gelatine, 3% acrylamide and 3% N; N0-methylene-bis-acrylamide by mass, with distilled water as 
the remaining constituent, and Nitrogen was introduced to eliminate any remaining oxygen from 
water. From their research, detection of variations in concentrations in both acrylamide and Bis 
[107, 111] and gelatine [112] will deliver various differences in sensitivity. Samples of PAG were 
subjected to irradiation utilizing a linear accelerator, and were photographed by using a 0.5 T (22 
MHz) Philips Gyroscan MRI scanner. The mean spin–lattice relaxation rate was calculated by 
utilizing a ‘turbo-mixed’ sequence, consisted of a series of 90° pulses, each pursued by attainment 
of a continuous spin echoes. The mean sensitivity for five different batches of PAG within the 
scope up to 10 Gy was measured to be 0:0285 s-1 Gy-1 for the mean spin–lattice relaxation rate with 
a percentage standard deviation of 1.25%. On the whole, replication between the batches was 
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calculated reaching 2.69%. This technique introduced innovative use of pre-filled nitrogen tubes for 
scaling, which is utilized to form methods by up loading anatomically shaped anthropomorphic 
phantoms [48]. 
 
1.6 Motivations for This Work 
 
In this thesis, it is necessary to emphasize that none has performed this kind of project before i.e., 
comparing different treatment planning data by using Cadplan and Pinnnacle 3, with different 
dosage IMRT and 4F, by applying low and high energy and using PAG gel dosimetry for prostate 
cancer radiation therapy. We will evaluate the use of same irradiation beam energy 6MV, with 
different doses, and compare the dose distribution between four field and IMRT by using Cadplan 
and Pinnacle treatment planning system. Furthermore, we will compare the experiment data with 
treatment planning data to see which commercial treatment planning is more effective. We will use 
irradiation beam energy 18MV to see the effects generated from different beam energies (low 
energy 6MV and high energy 18MV), and use DVH (RAH) to observe the difference of dose 
distribution between 4F and IMRT.  
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2. Method 
The description steps will follow the procedures undertaken in our experiment in order to display 
the dose distribution in three dimensions. The main steps include: PAG gel dosimeters preparation, 
planning the prostate cancer treatment plans for gel dosimeters using both Cadplan and Pinnacle 
computer planning systems, irradiation by linear accelerators using either conventional Four-field or 
IMRT technique, scanning the gel dosimeters by MRI scanner and analyzing data from the MRI 
images to obtain dose distributions of the gel dosimeters.  
 
2.1 Gel preparation 
 
The gels were formed at Professor’s D. Solomon research laboratory at the Chemical and 
Biomolecular Engineering Department at the Engineering Faculty, Melbourne University. Sixteen 
samples were prepared for different treatment options given in Table-1. The sample’s vessel is 
8.4cm in length and 5.2cm in diameter cylinder and the vessel is slightly larger than the prostate 
size, so that the dose distribution could be obtained throughout the prostate and to its surroundings. 
The Polymer- Acrylamide Gel (PAG) gels were made from de-ionised water, gelatin, acrylamide 
and N, N’-methylene-bis-acrylamide (BIS) in a glove box, see below (Figure-10) as seen in Table-2. 
Following the procedure described by some research papers [107], both glove box and de-ionised 
water were deoxygenated by bubbling humidified argon for at least one and a half hour [46, 47, 60, 
84, 108]. This is because oxygen is an inhibitor of PAG-type gel, and is a free radical scavenger. 
Therefore, it is required to prepare the gels in an oxygen free environment. The oximeter (Figure-9) 
was used to measure the percentage of oxygen remaining in water. The system was deoxygenated 
completely when the percentage of oxygen stayed below 0.5% for a few minutes and didn’t rebound. 
To ensure effective degassing, the water was stirred by using a magnetic stirrer continuously while 
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degassing. Acrylamide, BIS and gelatin were added separately after the water was heated up to 40
℃, and until a clear solution was obtained. Then, the gel solution was poured into the vessels. Para-
film was wrapped around the stopper and the opening part to protect the gels away from oxygen. To 
prevent ‘monomers’ photo-polymerization, the gel dosimeters were wrapped in light-proofed 
aluminum foil, which were then placed overnight in refrigerator to set for approximately 1 day. An 
enough time period was allowed for the gel to form a stable gelatine structure, which was 
considered sufficient for the gel to become solid. Since plastic materials are permeable to 
atmospheric oxygen, and they can dissolve oxygen by releasing it slowly into hypoxic media; 
therefore, the irradiation should be no later than 24 hours after the PAG gel dosimeters were ready 
for irradiation. 
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Table-1  Treatment options of PAG samples 
Sample Number Treatment Options 
1 Four-field 6MV 2Gy 
2 Four-field 6MV 6Gy 
3 Four-field 6MV 10Gy 
4 Four-field 18MV 2Gy 
5 Four-field 18MV 6Gy 
6 Four-field 18MV 10Gy 
7 IMRT 6MV 2Gy 
8 IMRT 6MV 6Gy 
9 IMRT 6MV 10Gy 
10 IMRT 18MV 2Gy 
11 IMRT 18MV 6Gy 
12 IMRT 18MV 10Gy 
13 Calibration 4Gy 
14 Calibration 6Gy 
15 Calibration 8Gy 
16 Control 
 
 
 
Table-2    Chemical composition of the PAG gel dosimeter 
Components /Chemicals Weight( %) 
Deionised Water 88 % 
Acrylamide (AAm) (ICN Biomedicals. Inc. Electrophoresis Grade, Cat. No. 
814249, Purity > 99.9 %) 
3.5 % 
N’ N-methylene-bis-acrylamide (BIS) (Aldrich Chemical Company. 
Inc.,Cat. No. 14,832-6, Purity 99 %) 
3.5 % 
Gelatin (Sigma G-2500 (approximately 300 Bloom), Type A) 5 % 
Total  100 % 
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Figure-9 The oximeter for the oxygen measurement in water (Oxi 330, WTW 82362 Weilheim, made in 
Germany, Ser-Nr. 82751020) 
 
 
 
 
 
Figure-10 Argon-filled glove-box  
 
Polymer-gel dosimeter was set up in Argon-filled gloved box, where the glove-box was emptied 
totally from gas for nearly 2 hours before utilizing it in order to remove the challenge of oxygen 
Tank of 
Argon Gas 
 
Gloved box 
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contamination. The chemicals, the de-ionised water and the vessels that enclosed the polymer-gel 
dosimeter were emptied from argon too (Fig-10).  
 
2.2 Treatment Planning and Verification 
 
In order to utilize effectively radiotherapy for the treatment of malignant tumors and at the same 
time be able to save the surrounding healthy tissues; thus, multiple parameters are needed to be 
taken into consideration: verify the main and suitable type of radiation, the appropriate dosage, the 
shape, size and number of radiation beams, and their geometric sites in relation to the tumor. 
Treatment planning refers to the course where all of these parameters are being taken into 
consideration in parallel with the help of treatment planning software, which assists in achieving 
this task. However, the 3 dimensional (3-D) geometry of patient is attained by a computerized 
tomography (CT) scan consisting of sequenced transverse images of the treated area in a patient. 
Essential structures and exterior shapes in a patient are outlined on each individual slice (2-D 
transversal planes) to permit reconstruction of the following structures in 3-D. The treatment 
planning software is utilized in order to measure the dose delivered at each locus within the patient 
volume from a delivered mixture of beams. The best planning of beams (number, energy, incidence 
angle, size, beam modifiers, etc.) for a specific treatment is established by maximizing the measured 
doses that are dispersed depending on the advices and criteria obtained from the physician’s 
prescription. The majority of treatment planning software needs to calculate beam data and semi-
experimental method in order to measure the total dose (total contribution of all beams) all over in 
the patient volume [106]. 
 
In this section the algorithms used for determining the delivered dose i.e. treatment planning will be 
briefly described as the following: first the gel phantoms are imaged using a CT scanner, then the 
obtained tomographic image is introduced into the treatment planning algorithms (where two types 
were explored in this work: CADPLAN and Pinnacle 3) which was employed to generate a plan to 
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deliver a preset dose to the target gel. Then the gel phantom is set up in the presence of the beam as 
indicated by the treatment planning. The procedure and the radiation dose are then accordingly 
delivered using a linac. 
 
2.2.1 Cadplan Computer Planning System 
 
In Peter MacCallum Cancer Institute, Cadplan-Helios (version 6.2.7), a product of Varian Medical 
Systems, was used to plan radiotherapy treatments. CT images from the gel phantom were scanned 
by CT scanner, and transferred via the computer network to Cadplan in DICOM (Digital Imaging 
and Communications in Medicine) format, and then converted to Cadplan’s proprietary format 
[113]. DICOM is a standard format for transferring and viewing medical images such as those from 
CT or MRI. Once the CT images are sent to the planning system, the relevant target volumes are 
marked and the beams are directed. The next step is to position the beams, set up the field sizes, 
design appropriate blocks, and select the wedges and so on. [114]. Once this is all completed the 
optimization process begins. The optimization of algorithm calculation of dose deposition 
coefficients uses Cadplan’s beam algorithm, and takes into account the anatomical and geometric 
information of the CT slices involved. After that, the plan for gel phantom is ready for irradiation. 
The IMRT and Four-field sample plans are attached in Appendix 3a and 3b. 
 
2.2.2 Dose Volume Histograms  
 
The dose volume histogram (DVH) is a tool employed to assess the radiation dose targeting a 
specific volume calculated by planning system. DVHs are measured using the treatment planning 
system by combining all the dose information for a shaped structure. With this method we can show 
the degree of disparity, but the main helpful illustration is a summary of DVH [115]. 
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Figure-11   A  DVH for an IMRT prostate treatment [115] 
 
Figure-11 shows a DVH for a prostate treatment. On this DVH the volumes shown are the rectum, 
bladder, right femur, left femur and the planning treatment volume (PTV). The dose received by the 
femurs is reasonably low (less than 5% of the volume receiving 50% of the total dose) in 
comparison with the dose to the PTV (60% of the volume receiving 100% of the dose). An ideal 
plan would have 100% of the PTV receiving 100% of the dose, while all of the significant 
structures would receive 0% of the dose. 
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Figure-12   A patient IMRT plan for a prostate cancer treatment.  
 
It is an image of an IMRT prostate cancer treatment plan using Cadplan planning system. The 
visible 5 beams are yellow indicating left and right femurs, the rectum outlined in blue and the 
target PTV is outlined in red. This plan corresponds with the DVH in Figure-11. The DVH shows 
that the rectum receives high dose to a large percentage of its volume; as for Figure-12 it shows 
proximity of the rectum to the PTV. 
 
2.2.3 Pinnacle 3 Treatment Planning System 
 
Pinnacle 3 (Pinnacle3™, ADAC Laboratories, Milpitas, CA Version 6.2b) uses a collapsed cone 
superposition convolution algorithm for photon dose calculation, and also employs a beam [116, 
117] model to speed up the optimization process for IMRT plan, which allows the user to specify a 
total minimum open area for each IMRT segment that can result in sub-segments along with widths 
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of only a few millimeters. The precision of Pinnacle3 dose determination for small areas was 
documented in Siemens Primus linear accelerators first work showing double focused multi-leaf 
collimators (MLCs) that took the role of lower jaws [118]. Francescon et al. [118, 119] recorded 
Pinnacle3 where they over calculated the dose by 8% for narrow 1.0 cm width photon segments. 
The IMRT and Four-field sample plans are attached in Appendix 3c and 3d. 
 
2.3 Gel Irradiation  
 
The gels were irradiated in a water phantom (Figure-13) at the Department of Radiation Therapy, 
Peter MacCallum Cancer Institute, and the Radiation Oncology Victoria (ROV). Both 6MV and 
18MV photon beams were applied using Varian Clinac 2100c linear accelerator (Figure-3a, 3b) (at 
both centers) for a set of doses at 2Gy, 6Gy and 10Gy, which were directed towards the localized 
iso-centre by a set of orthogonal laser beams. Figure-14 shows the phantom layout schematics. The 
dosimeters were exposed at room temperature of approximately 20°C where the dose-R2 response 
of PAG gel dosimeters looks comparatively insensitive to temperature ranges from 4°C to 22°C 
[139].  
 
At Peter MacCallum (using Cadplan treatment planning system) both 6MV and 18MV photon 
beams were used and only 6MV beam at Radiation Oncology Victoria (ROV) (using Pinnacle 3 
treatment planning system). Other parameters include: 10 X 10cm field size, 90cm for source-to-
surface distance (SSD), Four-Field Gantry (0, 90, 180, 270 degree), 5 field-IMRT Gantry (0, 45, 
115, 245, 315 degree), dose rate 400MU/min for 6MV and 600MU/min for 18MV, the couch angle 
(0 degree, that means coplanar beam was applied, all the beam axes were in the axial plane). As for 
the vessels ({inner diameter approximately 50 mm, length 84mm}, 125ml) for gel dosimeters and 
calibration samples. All the parameters listed were common and required by the irradiation. Other 
parameters were defaulted by the planning systems or not as common as those. All the parameters 
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were designed by the treatment planning systems. For the purpose of efficiency, all the parameters 
listed were set up as same when using the two planning systems. 
 
The gel vessels used for dose response evaluation (calibration samples) were irradiated at the same 
occasion with the same environment, also using 6 MV and 18MV photons. For the purpose of 
efficiency, the calibration samples were using the same size with IMRT and Four-field measurement 
samples. The gels are tissue/water-equivalent. In this work the gel phantom is made of many tiny 
dosimeters. Each point with the gel phantom can be treated as a point detector. The calibration was 
evaluated by selected points at the central axis of the gel samples where the same points were 
irradiated with different planning systems (Cadplan and Pinnacle) and techniques (4F and IMRT). 
The calibration was not focused on the whole gel phantom. However, gel calibration is an issue 
with a noted problem. But the effect is small and we compared the measured doses, so the errors 
will cancel out. 
 
Figure-13 Water phantom used for gel dosimeters. Represent the image of full scatter water phantom used 
for PAG gel dosimeters when taking measurements. 
 
A gel dosimeter 
in water phantom 
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Figure-14   The phantom layout schematic  
 
The gel dosimeter is placed in the centre of the phantom and the tap water is given time to reach 
room temperature so that the readings remain constant i.e. to prevent gel dosimeter from fluctuating 
with the change in water temperature, followed by filling the phantom to 7.3cm height above gels. 
The water’s depth used is based on the recommendations of the International Atomic Energy 
Agency’s technical report series number 398. 
 
2.4   MRI Evaluation 
 
In the early days of gel dosimetry, magnetic resonance imaging was suggested as the method to 
read-out the gel dosimeters. The use of magnetic resonance imaging as a non-destructive 
measurement of a gel dosimeter was first proposed in 1984 by J.C. Gore et al. [36]. In this study, the 
MRI scanning was used to measure the dose distribution by polymer gel dosimeters. 
2.4.1   Magnetic Resonance Imaging (MRI)  
 
Magnetic Resonance Imaging (MRI) is a tomographic imaging method produces images about the 
internal physical and chemical characteristics of an object from the outside, and is measured by 
nuclear magnetic resonance (NMR) signals [46]. MRI was developed from NMR phenomenon by 
Felix Bloch at Stanford and Edward Purcell at Harvard in 1946. However, the image formation 
using NMR signals is made possible by using spatial information encoding principles, which is 
52mm 
75mm 
Water 
Phantom  
202 mm 
Gel Dosimeter Tissue-equivalent 
Plastic blocks 
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originally coined zeugmatography that was developed by Paul Lauterbur in 1972 [120]. These 
principles enable one to uniquely encode spatial information into the activated MR signals detected 
outside an object. 
 
The spin-spin relaxation rate R2=1/T2 in polymer gel dosimetry is related to the amount of 
absorbed dose that is being distributed to a gel phantom with high-energy irradiation beams [40]. 
Taking two-points method, R2 is calculated from two various T2-weighted images. When many-
points method is applied, R2 is measured by corresponding with the pixel intensities of a set of 
various rapidly developing T2-weighted images [121]. An investigation about the impact of noise 
on the effect R2 image may supply significant improvement to the precision of the dose map. The 
relationship between the noise level in another way T2-weighted images and the noise level in the 
R2 image is extracted mathematically. This relation is reliant on the actual R2, on the preference of 
echo times in the series used, and appropriate algorithm.  
 
It was established that dose images attained from R2 images through calibration will hold the noise 
coming out from the noise in the R2 image and from the percentage dissemination coefficients of 
the calibration curve [85]. Optimizing the echo times is needed in order to enlarge the signal-to-
noise ratio (SNR) in the resultant R2 image for the both methods that are followed and for both the 
appropriate algorithms [122]. The numerical significance on the SNR as seen in some studies can 
also be applicable to other data sets displaying a mono-exponential performance; for example, 
diffusion measurements, and/or T1 relaxation [123, 124]. 
 
MR images are enormously rich in information content. The image pixel value generally depends 
on a host of inherent parameters, including the spin-lattice relaxation time T1, and the spin-spin 
relaxation time T2 [60, 85]. The imaging effects of these parameters can be suppressed or enhanced 
by another set of operator-selectable parameters, such as repetition time (TR), echo time (TE), and 
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flip angle [125, 126]. T2 is more effective than T1 for signal-to-noise ratio (SNR) using gel 
dosimeters [123, 127]. Many observations on the changes in the transverse NMR relaxation rate R2 
as a function of the absorbed dose under various experimental conditions have been reported [128, 
129], and several possible mechanisms are involved in explaining the changes in R2 have been 
suggested [40, 130]. Around ten years ago it was demonstrated that the dose distribution recorded in 
a gel dosimeter could be visualized and quantified with high resolution using MRI [132].  
 
2.4.2   MRI Scanning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-15, PICKER 1.5T MRI Scanner. 1.5T Field Strength. OR71 Active Shield short bore magnet. PD-250 
gradients (23mT/77SR). 
 
After one day of irradiation, the gels were examined by Picker 1．5T MRI scanner (Figure-15) and 
scanning for the whole body a scanner with a standard RF head coil was used. A fast spin-echo 
(FSE) sequencing [133] with 8 equidistant echo times was employed with echo time (TE) 12.5, 25, 
37.5, to 100 msec; repetition time (TR) 5 sec; field of view (FOV) 24cm; matrix size (MS) 256x256 
to get transversal R2 maps at section locations consistent to the sites of the radiographic films. The 
segment positions were ascertained depending on the marker lines that were depicted on the gel 
vessels. The irradiated vessels with 6-MV and 18-MV were examined each independently, and each 
vessel was scanned twice to ensure a good Radio Frequency (RF) consistent with imaged volume. 
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Around 43 slices were applied while the thickness of each slice was 1.5mm without gap. So, the 
middle 63mm cylinder volume of the gels was scanned [133]. Although some researchers reported 
that either spin-echo (SE) [134, 135] or multiple spin-echo (MSE) [135, 136, 137] sequence might 
get better resolution, FSE sequence were acceptable in this project since the major aims were the 
comparison of the two planning techniques (conventional Four-Field and IMRT) under different 
beam energy (6MV and 18MV) and different treatment planning system (Cadplan and Pinnacle 3). 
2.5   Data Analysis 
 
The data processing of MR images were carried out by a data analysis and custom program written 
with scientific computational program, Matlab (student version, Version 7.0.1.15 (R14) Service 
pack 1, The Math Works, Inc., Natick, Massachusetts). The program has calculated the rate of 
exponential decay from multiple TE images, and produced T2 values pixel-by-pixel, using the 
Levenberg–Marquardt optimization algorithm [85]. Then R2 value maps were formed by the 
equation R2 = 1/T2. Therefore, the dose distribution was obtained when using the calibration data. 
The three dimensional (3D) dose distributions could be obtained by combining several slices of 2D 
image data.  
 
To compare it with the planning data, a custom program written using Matlab was used to calculate 
the R2 value distributions for each MRI imaging slices (calculation algorithm sample attached in 
Appendix 1). Appendix 1 is widely applied to reduce the randomicity of the data for each pixel in 
this field. I made a program using Matlab code to calculate all the measurement data using this 
algorithm. In this case a 5x5-model was applied. Attention should be paid that the balance between 
the accuracy and randomicity errors is very important. Large area (such as 100x100) reduces the 
accuracy and small area (such as 1x1, 2x2) increases the system randomicity errors. Afterwards an 
experiment dose volume histogram (DVH) was produced to compare the DVH from planning 
system by using calibration data and combining all MRI imaging slices.  
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3. Results and Discussion 
3.1 Calibrations  
 
Since the experiments were performed independently with two treatment planning systems; hence, 
there was a need to establish two dosimetric calibrations for each one. The calibration is a way of 
transforming T2 (R2) to dose. It is observed that R2 varies linearly with the absorbed dose. The 
doses that have been tested in this experiment are 0, 4, 6, 8Gy. As we know, R2 value is linear to 
the dose delivery under 15Gy [138], and the equation: 
                   R2(x) = A * R2 (d) + R2(0) 
Where R2 (0) and A is the cut off and gradient of the line, while R2 (d) is the R2 value of the 
corresponding dose.  
 
The points were taken from the central slices crossing the central axis of the phantom which means 
the exact central point of the phantom in three dimensions. The calibration data for both Cadplan 
and Pinnacle 3 planning systems was attached in Appendix 2a.  
3.1.1 Calibrations for Cadplan Planning Experiments 
 
The calibration curve for experimental data while using e Cadplan Planning system is shown in 
Figure-16 below:  
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Figure-16  Calibration Curve for Cadplan 
 
Figure-16 shows the calibration curve for the experimental data using Cadplan Planning System; it 
was measured by 1.5T MRI scanner; the error bars (95% confidence) are too small to be seen on 
this graph. The figure shows linearity in the calibration where R2 is linear to the doses that are 
formed. From this graph, R2 value initializes at 1.75 S-1 (A) and the gradient of the line is 0.04 
(Gy.s) -1. 
 
3.1.2 Calibrations for Pinnacle 3 Planning Experiments 
 
The calibration curve for experimental data for using Pinnacle 3 Planning system is shown in the 
Figure-17.  
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Figure-17  Calibration Curve for Pinnacle 3 
 
Figure-17 shows the calibration curve for the experiment data using Pinnacle 3 Planning System. It 
was measured by 1.5T MRI scanner. The error bars are too small to be seen here (95% confidence). 
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The figure shows linearity in the calibration where R2 is linear to the doses that are formed. From 
this graph, R2 value initializes at 1.45 S-1 (A) and the gradient of the line is 0.07 (Gy.s) -1. 
 
3.1.3 Discussion of Calibrations 
 
When comparing the two calibration curves, the initial R2 values and slopes of the curves are 
different, but the differences are not that large. Several factors affect the Dose-R2 response curves, 
such as gels’ different composition, different oxygen content in the gels, different temperature upon 
irradiation and scanning, different beam energy and irradiation dose rate.  
 
One of the possible reasons behind the difference in Dose-R2 response curves in this experiment 
might be attributed to different batches of the gels [64]. In each experiment, gels were formed under 
same conditions, but because of variation in the batches of gels and different oxygen concentration 
some system errors should take place within the gels, which can lead to diverse characteristics of 
gels. As we mentioned in section 1.6.3 Polymer chemistry and hydrogel systems, more monomer 
compositions produces further polymers upon irradiation.  Oxygen within gels creates peroxide-
radicals, which react with other radicals leading to the termination of polymerization during 
irradiations [139]. This causes a low dose region of polymer gel dosimeters where oxygen appears 
as an inhibitor of the polymer gel dosimeters, although it can be removed from the gel system by 
degassing the gel solution with either nitrogen or argon gas [46]. So, different oxygen concentration 
causes different Dose-R2 response. However, in this experiment, each batch of gels had the same 
experimental environment; also the concentration of oxygen that was involved were controlled 
below 0.1% (standard level is under 0.5%, [140]), so the results were reliable and the minimum 
effects were reduced with the presence of oxygen. This is the reason why there is a need to establish 
a set of calibration samples for each experiment.   
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According to Figure-18 (Figure-18 is from literature. It was not mentioned which part of the 
phantom are related. In this project, the reason for the calibration points selected by the central of 
the phantom is to make easier calculation of the experiments. Other points are still suitable for the 
calibration within the gel phantom. The only attention should be paid is the calibration point should 
be same at the each experiment.) expressed in De Deene et al. [138], the slope (dose-sensitivity) of 
this experiment’s calibration is smaller than any BANG1, 2, 3 type of gels’ calibration; nevertheless, 
they are still similar with De Deene’s work [139]. This might be because of the compositions, 
especially the monomers selected for the gels. De Deene indicated that the monomer of the gel 
dosimeter with the highest R2 dose-sensitivity is methacrylic acid (1.193 s-1.Gy-1) and with the 
largest dose range is hydroxyl-ethyl methacrylate (D1/2 = 41.6 Gy) [139]. As a result, there are two 
criteria for dosimeters being selected and needs to be followed: 1) the R2-dose range is linear and 2) 
no non-linear (spatially dependent) dose responses occur within the operating dose range.  In this 
experiment, less than 10Gy dose were applied and measured; therefore, it could be recognized that 
the R2-dose range is following these two criteria. So, there was no doubt to use PAG gel dosimeter 
in this work.  
 
In practice, the optimum dose is being selected in a way where the R2-dose scope is utilized to the 
maximum. In this case, the two criteria should be achieved (1) the R2-dose scope is linear and (2) 
absence of non-linear (spatially dependent) dose reaction taking place within the driving dose scope. 
It is important to acknowledge that the primary criteria are not rigorous as the non-linear R2-dose 
reaction, which can be employed to calibrate the R2 maps. 
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Figure-18 Contrast of previous published BANG gel calibration data. Lines 1, 2 and 3 compatible to the data 
of Maryanski et al [47], Ibbott et al [85], and Oldham et al [141], correspondingly. 
 
Further realistic mirror images of the non-uniformities are the heterogeneous temperature change of 
the gel phantom while doing the scanning. Because of the RF signal strength captured by the gel, a 
temperature increase in the series of 1-3℃ is not measured as uncommon. Since the outer 
parameters of the phantom are surrounded by air temperature (usually in stream); hence, the 
disparities in the phantom will increase [50]. Since the T2 of dosimeter gel is T [℃] temperature 
dependent; hence, the dose imprecision’s contained by the group of 3-10% (comparing to the 
maximum dose) could be predicted. 
 
3.2   Dose Distributions Comparison between IMRT and Four-field 
 
In this section, the dose distributions were compared between IMRT and Four-field techniques utilization 
with some different types of results, such as Depth dose distributions, dose profile along the central axis of 
the gel dosimeters and Dose-Volume Histograms (DVH). Each result was performed by Cadplan and 
Pinnacle 3 treatment planning systems.  
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3.2.1   Depth Dose Comparison 
 
Because the Radio Frequency (RF) pulse will cause image distortions [142], a custom program 
written by Matlab was used to calculate the R2 value distributions for each MRI imaging slices 
(calculation algorithm sample attached in Appendix 1) to reduce the affects. The depth dose 
comparison data for both Cadplan and Pinnacle 3 planning systems was attached in Appendix 2b.  
 
Since the diameter of the gel vessels is 52mm, the thickness of the vessel wall is about 2mm, the 
depth dose distributions should be plotted at the middle part at 48mm of the central slice of MRI 
images. Because of the effects from the artifacts (discussed in Section 3.2.4.1), the results data from 
the three points near the gel vessel wall was particularly anamorphic. Therefore, three graphs 
(Figure 18-21) were plotted using the central 42mm of 48mm to present the dose perturbation 
within the planning target volume (PTV) of the gels. Two of them were using Cadplan treatment 
planning system by either 6MV or 18MV photon beam. The third graph was performed by Pinnacle 
3 treatment planning system 6MV photon beam only. 
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Figure-19 Depth dose distribution comparison graph for 6MV photon beam 10Gy between Four-Field and 
IMRT using Cadplan Planning System  
 
The graph (Figure-19) shows that doses correspond to the central MRI slices taken across the centre 
of the transverse irradiated volume. The dotted black line “outline” the area where the doses are 
obtained by IMRT technique to create the Depth Dose graphs (dose against Distance), while the red 
line by conventional four-field technique. 
 
 
Figure-20 Depth dose distribution comparison graph for 18MV photon beam 10Gy between Four-Field and 
IMRT using Cadplan Planning System  
 
The graph (Figure-20) shows that doses correspond to the central MRI slices taken across the centre 
of the traversed irradiated volume. The dotted black line shows the dose distributions using IMRT 
technique, while the red line by conventional four-field technique. 
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Figure-21  Depth dose distribution comparison graph for 6MV beam 6Gy between Four-Field and IMRT 
using Pinnacle 3 Planning System  
 
The graph (Figure-21) shows that doses correspond to the central MRI slices taken across the centre 
of the traversed irradiated volume. The dotted black line “outline” the area where the doses are 
obtained by IMRT technique to create the Depth Dose graphs (dose against Distance), while the red 
line by conventional four-field technique. 
 
These results data were normalized by the maximum dose from the treatment planning. The 
normalization of the results data is very important in order to compare them at a fair environment. 
When the plans were designed to deliver the dose to the target gels, IMRT plans were set at the 
minimum treatment dose to the whole target volume, while the four-field plan set at the maximum 
dose to the target centre. This deliverance of doses of the target volume from IMRT will always be 
higher than four-field without normalization. The plan was for cylindrical gel phantom to obtain 
reliable comparison between IMRT and four-field plans. The normalizations of the results were 
applied in this work apart from any specific indication.  
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These graphs show that IMRT always delivers higher dose to the target whether we used Cadplan or 
Pinnacle3 treatment planning system. The dose difference between IMRT and four-field were given 
in details as shown in Table 3.1. As we can see, the average depth doses delivered to the planning 
target volume (PTV) will be 10.26Gy for IMRT and 9.60Gy for four-field with 6MV photon beam, 
10.35Gy for IMRT and 9.59Gy for four-field with 18MV photon beam at 10Gy using Cadplan TPS. 
The dose differences between IMRT and Four-Field will be 6.6% and 7.6%, correspondingly with 
higher doses for IMRT. For Pinnacle 3 TPS experimental data, the average depth doses to PTV will 
be 6.33Gy for IMRT, and 6.05Gy for four-field using 6MV photon beam at 6Gy with corresponding 
4.7% higher dose to IMRT.  
 
Table 3.1 depth dose difference between IMRT and four-field 
 
Cadplan Pinnacle 3 
Plans 
IMRT 
6MV-
10Gy 
4F 
6MV-
10Gy 
IMRT 
18MV-
10Gy 
4F 
18MV-
10Gy 
IMRT 
6MV-
6Gy 
4F 
6MV-
6Gy 
Dose average (Gy) 10.26 9.60 10.35 9.59 6.33 6.05 
Dose average difference between 
experimental and TPS data (%) 
2.6 -4.0 3.5 -4.1 5.5 0.8 
Dose average difference between 
IMRT and four-field (%) 
6.6 7.6 4.7 
 
3.2.2   Dose Profile Comparison 
 
The dose profile along the central axis of the gel dosimeters shows that the vertical dose distribution 
is complementary to the transverse depth dose distribution. Here it shows us the dose distributions 
at certain depth (26mm depth of the gels, 100mm depth of the water phantom). The dose profile 
data for both Cadplan and Pinnacle 3 planning systems was attached in Appendix 2b. 
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From Figure-22 and 23 and Table-3.2, the doses along the central axis were uniform, similar as to 
the depth dose results. Since the graphs were plotted along the centre of the gels, it is common that 
the results data did not fluctuate as much as off-axis. The average doses are 10.45Gy for IMRT, and 
9.98Gy for four-field with 4.7% IMRT higher dose difference when using Cadplan TPS 6MV 
photon beam at 10Gy, while with 6.20Gy for IMRT and 5.89Gy for four-field with 5.1% IMRT 
higher in dose difference using Pinnacle 3 TPS.  
 
Figure-22  Dose profile along the central axis of the gel dosimeters at 10Gy using 6MV beam by Cadplan 
planning system 
 
 In Figure-22, each pixel along x-axis is 1.5mm. The black line shows the dose distribution using 
IMRT technique, while the red line by conventional Four-Field technique. The average dose for 
IMRT is 10.45Gy while 9.98Gy for Four-Field with 4.7% difference.  
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Figure-23 Dose profile along the central axis of the gel dosimeters at 6Gy using 6MV beam by Pinnacle3 
planning system  
 
In Figure-23, each pixel along x-axis is 1.5mm. The black line shows the dose distribution using 
IMRT technique, while the red line by conventional Four-Field technique. The average dose for 
IMRT is 6.20Gy while 5.89Gy for Four-Field with 5.1% difference. 
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Table 3.2 the dose differences along the central axis of the gel dosimeters between IMRT and four-
field 
 Cadplan Pinnacle 3 
Plans 
IMRT 
6MV-
10Gy 
4F 6MV-
10Gy 
IMRT 
6MV-
6Gy 
 4F 6MV-
6Gy 
Dose average (Gy) 10.45 9.98 6.2 5.89 
Dose average difference between 
experimental and TPS data (%) 
4.5 -0.2 3.3 -1.8 
Dose average difference between 
IMRT and four-field (%) 
4.7 5.1 
 
3.2.3 DVH Results Comparison 
 
Dose volume histogram (DVH) is an approach to display the dose-volume distribution in three-
dimensional treatment planning. An experimental dose volume histogram was produced to compare 
these two planning systems by using calibration data and combining all MRI imaging slices. 
Because the calibration curve can convert R2 value to dose; hence, combining all MRI imaging 
slices can apply the R2 value from area (2D) to volume (3D). The dose volume histogram data for 
both Cadplan and Pinnacle 3 planning systems was attached in Appendix 2d. 
 
As we can see from Figure-24 Cadplan TPS results, IMRT get closer and more effective dose to 
10Gy than with Four-Field. The reason because the doses of both IMRT and Four-Field start 
decreasing from about 8Gy while IMRT decreases less than Four-Field before 90% volume. Also at 
the 9.2Gy dose, IMRT covers 97.7% volume as Four-Field 85.6%. Afterwards, when the volume 
decreases from 80% to 20%, the corresponding dose ranges are 0.7Gy (9.8Gy to 10.5Gy) for IMRT, 
and 0.95Gy (9.25Gy to 10.2Gy) for Four-Field. It means that the dose of IMRT plan decreases 
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sharper than with Four-Field. The similar dose distribution trend is observed in Pinnacle3 TPS 
results. 
 
Clinically, it is also found that the dose with Four-Field plan decreases faster than IMRT. This leads 
to more doses and a larger volume delivered to the surrounding tissues when the same treatment 
dose applied by IMRT plan.   
 
Figure-24 Dose Volume Histogram comparison between IMRT and Four-field using 6MV beam at 10Gy with 
Cadplan planning system 
 
It (Figure-24) shows IMRT witness sharp decrease in dose volume starting above 9.4 Gy, whereas 
4F dose volume sharp decrease starts at 9.0Gy.  
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Figure-25 Dose volume Histogram comparison between IMRT and Four-field using 6MV beam at 10Gy with 
Pinnacle 3 planning system.  
 
It (Figure-25) shows IMRT witness sharp decrease in dose volume starting about 9.3Gy whereas 
Four-Field dose volume sharp decrease starts at 9.0Gy. The IMRT get closer and more effective 
dose at 10Gy than four-field. 
 
3.2.4   Discussion  
 
3.2.4.1   Inaccuracy from MRI Artifacts 
 
In this work, there are some factors that affect gel dosimetry. Some of them were discussed before 
in the calibration discussion section 3.1.3. From the results graphs, some MRI artifacts were 
observed according to Figure 18-21. MRI artifacts are reported by many researchers before [143], 
and are considered as the most important factors that can reduce the accuracy of the experiment 
results. There are many types of artifacts, which can be optimized more or less, but can not be 
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avoided completely. Mainly there are two kinds of artifacts that lead to different levels of inaccurate 
results in this work.  
 
As we can see, there are some sharp dose fluctuations observed at two sides of the depth dose 
distribution lines in Figure 18-21, either by IMRT or four-field. This was caused by a MRI artifact 
named Gibbs Ringing artifact [144, 145]. Gibbs Ringing artifacts are presented in the form of bright 
or dark lines, which are being observed in similar and within the neighboring boundaries of sudden 
intensity alteration. The ringing is attributed to the imperfect echo digitization, which indicates that 
the signal has not diminished totally to zero when it reaches the attained window. This designates 
that the echo is not completely digitized and the artifact is observed in images when an attained 
environment is being utilized. These artifacts which are regarded as normal image deformation is 
present in Fourier images; apparently, it is considered as false ringing around the sharp edges. So, 
Gibbs artifacts had been recognized as having the influence of affecting the restoration of images 
and causing discontinuities. Hence, these artifacts can bring a setback in restoring the MRI data 
collection, because of several various tissues that are present, whenever each scan is been 
performed. In this work, Gibbs Ringing artifacts were present at the boundaries between the gel and 
the vessel walls as the mass densities changed suddenly. However, Gibbs artifacts do not have the 
influence on our analysis of the middle part of depth dose distributions. If there is any interest 
among other researcher about the dose distribution at the boundaries our results then we could 
emphasize on larger sizes of gel dosimeters could be applied by contouring the same planning target 
volume (PTV). 
 
From the depth dose graphs, we can also see that the strength of doses decreases slightly from one 
side to another. This non-uniform dose is usually caused by other artifact- B1-field inhomogeneities 
[139; 143].  The basic reason behind these artifacts is because of the MRI machine, which has 
inhomogeneities magnetic field leading to inhomogeneities T2 values.  It might be involved in 
causing the dose errors in the order 3%-10%, depending on the maximum dose. There are numerous 
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means that are accountable for the non-consistencies in the standard spin-echo images. In the 
clinical MR-scanners settings, the non-consistencies in T1 and T2 images are mostly triggered by 
B1 field inhomogeneities. It is been acknowledged that B1 field are produced through a radio-
frequency coil which is not totally uniform. Therefore, the historical aspect of the spin magnetism is 
through a numerous spin echo series, which is dependent on the location of the nuclear instant in the 
slice; hence, the divergence in the R2 value will be dependent on the location [143]. Utilizing a 
computer reproduction to resolve Bloch equations for the numerous echo series can anticipate the 
connection of the calculated R2 with the regional B1 field. The reproductions are totally in 
agreement with the investigated results. When B1 field is plotted it is feasible to anticipate in what 
way the R2 divergence could vary with the slice location [143]. However, as for the comparative 
subject it won’t be considered as important as the absolute dose measurement. 
 
Some other artifacts might affect the results in my work, such as temperature above 22 ℃, 
Temperature drift during MRI scanning, eddy currents, B1-field inhomogeneities [139; 143; 146] 
and others but they were minimized or optimized, so they didn’t appear in our results. 
 
3.2.4.2   IMRT and four-field Comparison 
 
In this last section, the dose distributions of IMRT and four-field plans were presented 
independently by the depth doses, dose profiles along the central axis and DVHs. Therefore, there is 
a need to combine those results to observe the actual three dimensional dose distributions.  
 
All the result analysis from the three directions (transverse, vertical and whole volume) shows the 
dose distributions for both IMRT and Four-Field plans, which are consistent and accurate; however, 
some differences do exist in those results. The average depth dose differences between the two 
techniques are more (6.6% for 6MV and 7.6% for 18MV beam at 10Gy by Cadplan TPS) or less 
(4.7% for 6MV at 6Gy by Pinnacle 3 TPS) significant, with IMRT plan delivering more dose, 
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although the normalization process was performed. Same complications occurred in dose profile 
results, with the average dose differences 4.7% for 6MV at 10Gy by Cadplan TPS, and 5.1% for 
6MV at 6Gy by Pinnacle 3 TPS. It is reasonable to understand that higher isocentric doses are 
required while utilizing IMRT technique in order to acquire the same coverage of the PTV [28]. 
However, more attention should be paid when the average isocentric dose difference (4.7%) is less 
than the average depth dose difference (6.6%) in Cadplan plan results, but in the Pinnacle plan 
results no significant difference was found. That means the off-axis dose differences are higher than 
isocentric dose difference. There are two possibilities for this phenomenon: either the dose had 
decreased more in the four-field plan or the dose increased more in the IMRT plan at off-axis area. 
The DVHs (Figure-24) indicates that the dose for four-field plan decreased more than IMRT at the 
same volume. This leads to a dose difference increasing at off-axis area for the four-field plan. The 
same occurrence is insignificant in Pinnacle 3 TPS results because the dose is not uniform due to 
the off-axis scatter dose delivered with four-field plan. 
 
It has to be noted that the 2D conventional four-field technique still delivers a uniform, homogenous 
dose to the prostate where it is more applicable than IMRT, such as when dose coverage should 
include the surrounding lymph nodes in later stages of the prostate cancer [28].   
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3.3 Verification of Energy Dependence 
 
 
Figure-26 Depth dose distribution comparison graph for IMRT plan at 10Gy by 6MV and 18MV photon 
beams using Cadplan TPS.  
 
Figure-26 shows that doses correspond to the central MRI slices taken across the centre of the 
traversed irradiated volume. The dotted black line “outline” the area where the doses are obtained 
by 6MV beam to create the Depth Dose graphs (dose against Distance), while the red line by 18MV 
beam. 
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Figure-27 Depth dose distribution comparison graph for four-field plan at 10Gy by 6MV and 18MV photon 
beams using Cadplan TPS.  
 
Figure-27 shows that doses correspond to the central MRI slices taken across the centre of the 
traversed irradiated volume. The dotted black line “outline” the area where the doses are obtained 
by 6MV beam to create the Depth Dose graphs (dose against Distance), while the red line by 18MV 
beam. 
 
Table 3.3 the depth dose difference between 6MV and 18MV photon beams  
 Dose average (Gy) Dose different 
using IMRT (%) 
Dose different 
using 4F (%) 
IMRT6MV-10Gy 10.26 
IMRT18MV-10Gy 10.35 
0.9 
 
4F6MV-10Gy 9.59 
4F18MV-10Gy 9.60 
 
0.1 
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From the results above, we can’t see significant dose difference between 6MV and 18MV beam 
using either IMRT or four-field technique, although the dose difference using IMRT was slightly 
higher than the Four-Field. Recently, one of the research results has disclosed that secondary 
neutron dose is produced much more with higher energy (>10MV) than lower energy, by using 
IMRT than conventional four-field upon irradiation. It was reported measurements of secondary 
neutron dose from 15MV and 18 MV IMRT [147] that the ambient dose equivalent for IMRT 
18MV is 15.26 mSv/Gy, while for conventional Four-Field is 2.49 mSv/Gy.  
 
According to De Deene’s report [139] for energy dependence, there is no significant dose-R2 
response change for PAG gel dosimetry within 0-10Gy when using 6MV and 18MV. My results 
verified this exactly.   
 
According to the recent research [148], the surface dose for the IMRT plan was measured more than 
in the Four-Field box plan with 15% to 30%, depending on the number of the beams used in the 
plan. The reason for this is that the monitor units (MUs) for IMRT are more than in the Four-Field 
due to the MLC that is applied. For low energy (6MV), the average surface dose was found to be 
more than high energy (15MV).  
 
The exterior doses of 6- and 15-MV prostate intensity-modulated radiation therapy (IMRT), the 
irradiations were calculated and evaluated to those from a 15-MV prostate 4-beam box (FBB). 
IMRT plans (step-and-shoot technique) using 5, 7, and 9 beams with 6- and 15-MV photon beams 
were produced from a Pinnacle treatment planning system (version 6) utilizing computed 
tomography (CT) scans from a Rando Phantom (ICRU Report 48). The metal oxide semiconductor 
influences the field effect transistor detectors, and were positioned and utilized on a transverse 
curve line along the Phantom surface at the core beam axis of measurement. The goals were to 
examine: (1) the input of the dynamic multileaf collimator (MLC) to the exterior dose throughout 
the IMRT irradiation; (2) the consequences of photon beam energy and the number of beams 
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employed in the IMRT plan on the external dose. The results illustrated that with similar number of 
beams utilized in the IMRT plan, the 6-MV irradiation provided more exterior dose than that of 15 
MV to the phantom. However, when the number of beams in the plan was elevated, the external 
dose variations between the over 2 photon energies turn out to be less.  
 
The average exterior dose of 15-MV IMRT irradiation was elevated with the number of beams in 
the plan, from 0.86% to 1.19%. On the contrary, for 6 MV the exterior dose diminished from 1.33% 
to 1.24% as the beam number was elevated from 7 to 9. By comparing the 15-MV FBB and 6-MV 
IMRT plans with 2 Gy/fraction, the IMRT irradiations has provided, in general, more exterior dose, 
from 15% to 30%, which depended on the number of beams in the plan. It was established that the 
elevation in the exterior dose for the IMRT method in comparison to the FBB plan was mainly due 
to the number of beams and the analyzed monitor units needed to distribute the similar dose at the 
isocenter in the plans. The lead difference is attributed to the dynamic MLC motion which involved 
in altering the exterior dose dispersal on patient was reproduced by the IMRT dose-strength map. 
Although the prostate IMRT in this study had an average of superior exterior dose than that with 
FBB, the additional equal dispersal of comparatively lesser exterior dose in the IMRT field could 
steer a clear large dose climax at the exterior locations immediately beneath the FBB fields. Such an 
equal and minimal exterior dose dispersal bordering the patient in IMRT is supposed to provide 
lower skin problems than that of FBB with similar recommended dose. 
 
Various prostate IMRT plans (5, 7, and 9 beam) were produced for a Rando Phantom and the doses 
about its transverse exterior line at the beam core axis were calculated using MOSFET sensing 
device. The MOSFET sensing device has been well identified as precise and suitable dosimeter for 
the calculation of exterior dose in mega-electron voltage photon beams. When applying IMRT plans 
utilizing the similar number of beams but dissimilar photon beam energies (6 and 15 MV), the 15-
MV plan has lower external dose measurement than that of 6 MV (about 5–30%, varying on the 
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number of beams). However, attention should be paid concerning neutron dose and radiation 
protection carried by the 15-MV photon beam. For the 15-MV IMRT plans employing diverse 
numbers of beams, the external dose measurements are elevated with the number of beams in the 
plan. However, for the 6-MV plan the calculated external dose will elevates from the 5- to 7-beam 
plan, and then falls at the 9 beam. The reduction in the external dose employing the 9-beam plan is 
attributed to the decrease of the computed MU in comparison to that in the 5- and 7-beam plan. In 
contrast to the FBB plan, the dispersal of exterior dose along the transverse external contour about 
the Phantom is more uniform in the IMRT plans, particularly when a larger number of beams are 
utilized. Such uniform external dose dispersal reproduces a less skin problems value in the patient, 
even though the total exterior dose calculated in the IMRT is still higher than that of the FBB plan. 
Moreover, the IMRT plans usually stay away from the very elevated exterior dose climaxes in the 
FBB example, where particular exterior regions were exactly beneath the fields. For the 6-MV 
IMRT plans with diverse numbers of beams employed, the exterior doses for the IMRT plan 
calculated were about 15–30% larger than it is in the 15-MV FBB. Hence, the elevation in the 
exterior dose in the IMRT plan is commonly manipulated by the beam energy, by the elevation of 
measured MU, the number of beams, and the IMRT dose strength map (i.e., the dynamic MLC 
movement during the irradiation) compared to the FBB.  
 
Thus, care should be taken regarding secondary neutrons produced by high energy photon beam, 
and comparatively increasing the surface dose by low energy. So, there are no conclusive 
suggestions for the selected energy needed to be applied for radiotherapy treatment of prostate 
cancer.  
 
3.4   Verification of Treatment Planning Dependence 
 
Two commercial treatment planning systems (Cadplan and Pinnacle3 ADAC) were used to 
calculate the IMRT and Four-Field treatment plans with the same gel phantom but independently. 
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The coplanar plans of the IMRT and Four-Field techniques are displayed in Figure-28 and 29 by 
using Cadplan and Pinnacle TPS.  
 
                               (a)                                                                   (b) 
Figure-28 Isodose distributions of a transverse slice through the central slice of the gel phantom. (a) Four-
Field and (b) IMRT, illustrating 6MV photon beam at 10Gy by Cadplan Treatment Planning System. 
 
 
                               (a)                                                                (b)  
 
Figure-29 Isodose distributions of a transverse slice through the central slice of the gel phantom. (a) Four-
Field at 6Gy and (b) IMRT at 2Gy, illustrating 6MV photon beam by Pinnacle 3 ADAC Treatment 
Planning System. 
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Figure-30 Dose volume Histogram comparisons between Cadplan and Pinnacle TPS using 6MV beam at 
10Gy with IMRT technique.  
 
 
Figure-31 Dose volume Histogram comparisons between Cadplan and Pinnacle TPS using 6MV beam at 
10Gy with four-field technique.  
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In order to compare these two planning systems, the results of the depth dose distributions, dose 
profiles along the central axis and the DVHs will be discussed mutually in this section. From Table 
3.1, we can see the average depth dose differences between experimental and TPS data are 2.6% for 
IMRT plan and -4.0% for four-field plan by 6MV beam, and correspondingly 3.5% and -4.1%by 
18MV beam at 10Gy using Cadplan TPS; and 5.5% for IMRT plan and 0.8% for Four-Field plan by 
6MV beam at 6Gy using Pinnacle 3 TPS. Also, the average dose differences along the central axis 
between experimental and TPS data are 4.5% for IMRT plan and -0.2% for Four-Field plan by 
6MV beam at 10Gy using TPS; and 3.3% for IMRT plan and -1.8% for four-field plan by 6MV 
beam at 6Gy using Pinnacle 3 TPS. As we discussed in section 3.2.4.2, the off-axis dose differences 
between IMRT and four-field plan are higher than isocentric dose difference when Cadplan TPS 
was applied; the dose for four-field plan had decreased more than IMRT at the same volume 
according to the DVHs in Figure 24 and 25.  
 
Therefore, Figure 30 and 31 were designed to compare these two treatment planning systems with a 
fair environment. It is very clear in Figure 30 that for IMRT plan both TPSs delivers the planning 
dose (10Gy) to the most volume of PTV (more than 98%). However, the dose for Pinnacle 3 TPS 
starts to decrease slightly earlier and sharper than Cadplan. In the same way, in Figure 31, even the 
dose for Cadplan four-field plan has slightly more volume to deliver at 10Gy planning dose to PTV, 
10Gy planning dose for Pinnacle 3 still has about 94% of the volume. Furthermore, the dose for 
Pinnacle 3 TPS starts to decrease slightly earlier and sharper than Cadplan same as IMRT plan.  
 
These differences between two commercial treatment planning systems might be partially caused by 
the pitfalls [149] and optimization algorithm [150] with Cadplan planning system as reported before. 
However, these differences are almost statistically insignificant in terms of the accuracy and system 
errors of the experiments.  
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In conclusion, generally both Cadplan and Pinnacle 3 TPS can be used to produce a uniform and 
accurate plan for prostate cancer radiotherapy treatment with insignificant differences. Meanwhile, 
the maximum doses will be delivered to the tumor target by sparing the surrounding normal tissues, 
which is the most important principle for prostate cancer radiotherapy treatment.  
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4.  Conclusion 
4.1     Conclusions  
 
A PAG gel dosimeter is a method verifying dose delivered for prostate cancer radiotherapy 
treatment, which has been evaluated in this work. A comparison of DVH for cylindrical PTV 
between the two treatment plans was verified experimentally. MRI response, an irradiated 
cylindrical gel phantom have been used for deriving of the depth dose through the vertical diameter 
of the central slide and central axis of the gel phantom, which was irradiated by 6 and 18 MV 
photon fields. The possibility was demonstrated of manufacturing gel dosimeters suitable for 3D 
dosimetry in the dose range. The results show that IMRT technique not only provides a better 
conformal dose to the prostate target volume than conventional Four-field technique, but also 
reduces doses to the surrounding normal tissues, although the treatment time will be extended as 
more monitor units (MUs) are required to construct the same isocentre dose in the treatment. There 
are no substantial differences between 6MV (low) and 18MV (high) beam energy in treatment. 
Both Cadplan-Helios and Pinnacle 3 treatment planning systems can produce a uniform and 
considerably equivalent dose plan. Furthermore, in terms of the experimental results for target dose 
coverage and adjacent normal tissues sparing, there is no substantial significant evidence to show 
the differences between the two treatment planning systems. The verification of the dose 
distribution surrounding the prostate target is not a topic in this thesis.   
  
4.2  Future Work 
 
This research demonstrates that polymer gel dosimetry is a promising method to measure the dose 
distribution in three dimensions. Some future-related directions could be followed. The radiation-
induced polymerization of gel dosimeter can also lead to some other alterations in the internal 
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characteristics of the gels. Therefore, some other techniques could be used to image the dosimeters 
in order to obtain these changed properties, such as X-ray Computed Tomography (CT), optical 
Computed Tomography and ultrasound.  
 
The critical surrounding tissues of the prostate could be involved in the measurement by using 
larger size gel dosimeters or several combined small dosimeters which are shape-simulated with 
target organs, such as rectum and bladder. However, when the combined dosimeters are used, one 
has to pay attention that the thickness of gel containers should not be too large, otherwise the dose 
at that area could not be measured precisely. Also if the critical doses to such surrounding tissues 
are attached to the calculations of treatment planning, it will provide a great step for clinical 
treatment.  Further studies can also be investigated, such as dose verification for prostate cancer 
patients with high atomic number (Z) hip prostheses, although it has been researched by some 
groups using different dosimeters [151, 152]. 
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6. Appendix 
Appendix 1 
 
The following graph is the illustration of how the R2 value for a certain position is calculated.  
11  14  18  16  15 
14  17   9    8   10 
11  12  20  17  15 
13  17  18  12  20 
21  12  23  22  18 
The R2 value for this position is 
taken the median value from this 
5x5 area. In this sample, the 
median value is 15. Then the 20 is 
replaced by the 15 as the R2 value 
for this pixel. 
 84 
Appendix 2  
 
Raw data for the experiments. 
2a. Calibration Data 
 
Cadplan calibration 
Dose (Gy) 0 4 6 8 
R2 value (1/Sec) 1.75 1.9 2 2.06 
     
Pinnacle calibration 
Dose (Gy) 0 4 6 8 
R2 value (1/Sec) 1.45 1.73 1.84 2.01 
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2b. Depth dose data 
 Cadplan Pinnacle 3 
Depth 
(mm) 
IMRT6MV-
10Gy 
4F6MV-
10Gy 
IMRT18MV-
10Gy 
4F18MV-
10Gy 
IMRT 
6MV-6Gy 4F 6MV-6Gy 
1 10.54 10.27 10.69 10.30 5.54 5.36 
2 12.52 12.24 11.92 11.36 6.48 5.94 
3 10.48 8.99 9.66 9.69 6.54 6.22 
4 11.23 10.88 10.79 10.24 6.06 5.94 
5 10.51 9.74 10.22 9.65 6.01 5.80 
6 10.71 10.07 10.18 9.72 6.18 5.85 
7 10.49 9.74 10.09 9.86 6.18 5.83 
8 10.60 10.29 10.55 10.09 6.34 5.91 
9 10.78 10.05 10.23 9.87 6.25 6.05 
10 10.93 10.18 10.34 9.77 6.19 5.86 
11 10.79 9.94 10.48 9.92 6.30 5.93 
12 11.01 10.24 10.52 10.00 6.28 5.99 
13 10.93 9.87 10.34 9.86 6.24 5.88 
14 10.62 10.05 10.52 10.00 6.40 5.95 
15 10.53 9.92 10.46 9.91 6.22 5.83 
16 10.46 9.82 10.39 9.81 6.18 5.72 
17 10.69 9.91 10.58 9.99 6.07 5.73 
18 10.40 9.93 10.62 9.62 6.26 5.80 
19 10.52 9.68 10.46 9.88 6.09 5.87 
20 10.64 9.85 10.44 9.94 6.08 5.84 
21 10.58 9.87 10.69 9.76 6.27 5.86 
22 10.79 9.98 10.53 9.63 6.24 5.99 
23 10.64 9.67 10.71 9.76 6.17 6.00 
24 10.60 9.97 10.62 9.72 6.11 5.94 
25 10.62 9.68 10.47 9.92 6.18 5.97 
26 10.68 9.49 10.33 9.70 6.20 5.85 
27 10.41 9.59 10.54 9.54 6.28 5.86 
28 10.52 9.84 10.37 9.76 6.33 6.11 
29 10.50 9.61 10.62 9.52 6.37 5.97 
30 10.37 9.88 10.52 9.21 6.25 5.78 
31 10.05 9.47 10.55 9.74 6.36 5.88 
32 10.20 9.25 10.20 9.22 6.33 5.95 
33 10.01 9.15 10.43 9.31 6.41 6.03 
34 9.87 9.05 10.14 9.24 6.24 5.89 
35 10.28 9.36 10.07 9.45 6.33 6.10 
36 9.61 9.08 9.77 9.14 6.43 6.22 
37 9.81 8.94 9.84 9.21 6.55 6.11 
38 9.51 8.94 9.61 8.72 6.47 6.18 
39 9.44 9.18 10.02 9.08 6.44 6.32 
40 9.66 8.83 9.82 8.93 6.59 6.14 
41 9.87 8.79 10.23 9.47 6.51 6.39 
42 9.61 9.09 9.65 9.03 6.74 6.37 
43 9.81 8.80 9.54 9.13 6.64 6.43 
44 9.21 8.37 9.82 9.14 6.65 6.52 
45 10.30 9.08 10.67 9.66 6.40 6.82 
46 9.11 8.03 8.73 8.40 7.20 6.52 
47 10.66 9.99 9.62 9.35 6.59 7.20 
48 8.86 8.37 9.03 8.16 6.91 6.79 
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2c. Dose profile data 
 
 Cadplan Pinnacle 3 
Position (mm) 4F 6MV-10Gy IMRT 6MV-10Gy IMRT6Gy 4F6Gy 
1 10.05 10.44 6.14 5.88 
2.5 10.06 10.48 6.22 5.95 
4 10.14 10.51 6.17 5.93 
5.5 10.10 10.52 6.20 5.94 
7 10.15 10.53 6.16 5.95 
8.5 10.09 10.53 6.22 5.91 
10 10.01 10.43 6.19 5.93 
11.5 10.01 10.39 6.15 5.92 
13 10.06 10.37 6.15 5.89 
14.5 10.01 10.36 6.13 5.85 
16 9.95 10.37 6.23 5.84 
17.5 9.93 10.38 6.30 5.89 
19 9.86 10.35 6.27 5.93 
20.5 9.86 10.31 6.31 5.96 
22 9.84 10.36 6.31 5.97 
23.5 9.85 10.39 6.32 6.03 
25 9.98 10.46 6.30 5.98 
26.5 10.01 10.47 6.25 5.96 
28 10.08 10.51 6.18 5.94 
29.5 10.04 10.48 6.17 5.96 
31 10.08 10.45 6.17 5.95 
32.5 10.07 10.49 6.17 5.94 
34 10.02 10.46 6.15 5.94 
35.5 9.99 10.49 6.16 5.94 
37 10.00 10.45 6.24 5.94 
38.5 9.90 10.50 6.28 5.95 
40 9.87 10.48 6.33 5.96 
41.5 9.90 10.50 6.29 5.92 
43 9.93 10.47 6.26 5.91 
44.5 9.92 10.41 6.25 5.88 
46 9.95 10.47 6.18 5.83 
47.5 9.94 10.51 6.17 5.81 
49 10.00 10.54 6.16 5.80 
50.5 9.98 10.55 6.16 5.80 
52 9.93 10.51 6.13 5.77 
53.5 9.93 10.47 6.10 5.74 
55 9.97 10.44 6.09 5.73 
56.5 9.91 10.42 6.08 5.67 
58 9.94 10.40 6.14 5.79 
59.5 9.89 10.41 6.20 5.84 
61 9.97 10.39 6.23 5.88 
62.5 9.95 10.42 6.26 5.88 
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2d. Dose volume histogram  
 
Dose (Gy) Volume (%) IMRT 6MV 10Gy Dose (Gy) 
Volume (%) 
4F 6MV 10Gy 
 Pinnacle Cadplan  Pinnacle Cadplan 
0 100 100 0 100 100 
0.5 100 100 0.5 100 100 
0.9 100 100 0.9 100 100 
1.3 100 100 1.3 100 100 
1.7 100 100 1.7 100 100 
2.1 100 100 2.1 100 100 
2.5 100 100 2.5 100 100 
3.0 100 100 2.8 100 100 
3.4 100 100 3.2 100 100 
3.9 100 100 3.5 100 100 
4.3 100 100 4.5 100 100 
4.8 100 100 5.3 100 100 
5.3 100 100 6.1 100 100 
5.8 100 100 7.0 100 100 
6.3 100 100 7.9 100 100 
6.8 100 100 8.8 99.6 99.9 
7.3 100 100 8.9 98.4 98.6 
7.8 100 100 9.0 96.1 96.2 
8.4 100 100 9.1 91.6 92.7 
8.6 100 99.9 9.2 83.4 85.6 
8.8 99.9 99.4 9.3 69.8 76.7 
9.0 99.0 98.7 9.5 56.0 64.1 
9.2 97.7 97.7 9.7 38.1 48.2 
9.4 93.8 95.3 9.9 24.1 33.6 
9.6 86.6 90.3 10.2 14.5 20.4 
9.8 71.5 81.6 10.4 8.4 12.7 
10.0 47.3 64.1 10.6 4.2 7.9 
10.2 24.2 41.5 10.8 2.3 4.3 
10.4 12.3 24.4 11.0 1.3 3.1 
10.6 5.7 14.5 11.1 0.3 2.0 
10.8 2.8 8.8 11.2 0 1.4 
11.0 1.2 4.7 11.3 0 0.8 
11.2 0 3.1 11.4 0 0.1 
11.4 0 1.9 11.5 0 0 
11.6 0 1.2 11.6 0 0 
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Appendix 3  
Treatment planning data  
3a. Cadplan 18MV IMRT plan 
 89 
3b. Cadplan 18MV four-field plan
 90 
3c. Pinnacle 6MV IMRT plan  
 91 
3d. Pinnacle 6MV four-field plan 
 
